Vesiculobullous Disorders for NEET PG Dermatology: Pemphigus, Bullous Pemphigoid, Nikolsky Sign, Immunofluorescence, Dermatitis Herpetiformis

Start Here

🎯 Exam priority: High. Expect: flaccid vs tense blisters, the level of split, desmoglein 3 vs 1, BP180/BP230, Nikolsky and Asboe-Hansen signs, immunofluorescence patterns (cell-surface, linear, granular), oral lesions in pemphigus, drug-induced pemphigus and pemphigoid, dermatitis herpetiformis with coeliac disease and dapsone, and ICMR treatment by body surface area.

CBME mapping: DR 13.1–13.2. Coeliac disease is also in Medicine; dapsone in Pharmacology.

Pemphigus vulgaris, bullous pemphigoid and dermatitis herpetiformis compared; ICMR treatment; work-up

Pemphigus vulgaris, bullous pemphigoid and dermatitis herpetiformis compared; ICMR treatment; work-up. Drawn by TrackNation.

Approach to a Blistering Patient (ICMR)

  • Look at the blister: flaccid blisters and erosions ± crusts on skin and mucosa → pemphigus group (adults). Tense blisters with clear or haemorrhagic fluid on an itchy, red or urticarial base, healing with hypopigmentation → subepidermal disease; bullous pemphigoid is the commonest.

  • A child under 5 with erosions ringed by tense blisters on an urticarial base, on the face or around the genitals → chronic bullous disease of childhood (linear IgA disease).

  • Tests: Tzanck smear; biopsy from the margin of a lesion for histology; perilesional biopsy for direct immunofluorescence.

  • Differentials: bullous impetigo, varicella, SJS/TEN, epidermolysis bullosa (infancy, pressure sites, scarring, teeth and nail changes); congenital syphilis in a neonate — VDRL for mother and child.

  • Red flags: fever with chills and rigors, hypotension (fluid loss or sepsis), altered sensorium. Care: monitor vitals, fluids and electrolytes, cultures, clean non-adherent dressings, dilute potassium permanganate soaks, chlorhexidine mouthwash, soft diet. Do not deroof blisters — the roof is a natural dressing; aspirate large ones with an 18G needle.

Disease

Target

Direct immunofluorescence (MSD)

Clue

Pemphigus vulgaris

Desmoglein 3 (± 1), IgG

IgG on keratinocyte cell surface

Oral erosions first; Nikolsky +

Pemphigus foliaceus

Desmoglein 1, IgG

IgG on keratinocyte cell surface

Superficial crusted erosions; mucosa spared

Bullous pemphigoid

BP180, BP230, IgG

Linear IgG and C3 along basement membrane zone

> 60 y; tense itchy bullae; Nikolsky −

Dermatitis herpetiformis

Gluten-related, IgA

Granular IgA in dermal papillary tips

Elbows, knees, buttocks; coeliac

Pemphigus

  • Pemphigus vulgaris: middle-aged adults; IgG against desmoglein 3 (± 1) → acantholysis and intraepidermal blisters. About half have only oral erosions, and oral lesions often come before skin lesions (painful mouth, poor intake). Nikolsky (epidermis shears with sideways pressure) and Asboe-Hansen (pressure spreads the bulla) signs are positive. Untreated, it is often fatal within 5 years. Variants: pemphigus vegetans (folds), paraneoplastic pemphigus.

  • Pemphigus foliaceus: IgG against desmoglein 1, superficial split, crusted erosions, mucosa rarely involved; drugs — penicillamine, nifedipine, captopril; endemic form fogo selvagem; pemphigus erythematosus on the cheeks.

  • ICMR treatment (only where monitoring exists): mucosal or < 5% BSA — prednisolone 0.5 mg/kg/day with azathioprine, mycophenolate, cyclophosphamide, methotrexate or dapsone; > 5% BSA — stabilise and refer; tertiary — dexamethasone–cyclophosphamide pulse or rituximab (MSD lists rituximab as first line).

Bullous Pemphigoid and Dermatitis Herpetiformis

  • Bullous pemphigoid: commonest autoimmune blistering disease, mostly over 60. IgG against hemidesmosomal BP180 and BP230 → complement → subepidermal blister (lamina lucida) rich in eosinophils. Itchy urticarial plaques, then tense bullae on trunk and flexures; mucosa rarely; Nikolsky negative; DIF — linear IgG and C3 along the basement membrane zone. Drug triggers include DPP-4 inhibitors (gliptins) and PD-1 inhibitors.

  • ICMR: limited (< 10% BSA) — topical clobetasol up to 30 g/day ± prednisolone 0.5 mg/kg/day ± dapsone, doxycycline, niacinamide or immunosuppressants; extensive (> 10%) — prednisolone 0.75–1 mg/kg/day at tertiary level.

  • Dermatitis herpetiformis: intensely itchy papulovesicles on extensor elbows and knees, sacrum, buttocks and occiput; nearly all have (often silent) coeliac disease; DIF — granular IgA in dermal papillary tips; tTG and endomysial IgA support it. Treat with dapsone (test G6PD first; haemolysis, methaemoglobinaemia) and a strict gluten-free diet, which can later stand alone. Risk of small-bowel lymphoma.

Traps the Examiner Sets

  • Mouth ulcers before skin blisters in a middle-aged adult → pemphigus vulgaris.

  • Elderly, itchy, tense blisters, Nikolsky negative → bullous pemphigoid.

  • Linear IgG = pemphigoid; granular IgA in papillae = dermatitis herpetiformis.

  • Never deroof blisters; check G6PD before dapsone.

Memory Hooks & Shortcuts

Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.

  • 🧠 'Vulgaris = mouth first (Dsg3); Foliaceus = superficial Flakes, mouth Free (Dsg1)' — pemphigus types

  • 🧠 'Pemphigoid = Pensioners, Pruritus, Pressure-tense blisters' — bullous pemphigoid

  • 🧠 Immunofluorescence: 'Pemphigus Paints cell surfaces; Pemphigoid Pencils a Line; DH Dots the papillae' — DIF patterns

  • 🧠 DH = 'Dapsone + Diet (gluten-free)' — dermatitis herpetiformis

  • 🧠 Blister roof = 'nature's dressing — never deroof' — care

Rapid-Revision Cards

  • Flaccid blisters

    Pemphigus group.

  • Tense blisters

    Subepidermal; pemphigoid commonest.

  • PV antigen

    Desmoglein 3 (± 1).

  • PF antigen

    Desmoglein 1; mucosa spared.

  • PV first sign

    Oral erosions.

  • Nikolsky

    Epidermis shears: PV +, BP −.

  • Asboe-Hansen

    Bulla spreads on pressure.

  • PV DIF

    IgG on keratinocyte surface.

  • PF drugs

    Penicillamine, captopril, nifedipine.

  • BP age

    > 60 years.

  • BP antigens

    BP180, BP230.

  • BP DIF

    Linear IgG + C3 at BMZ.

  • BP drug

    DPP-4 inhibitors.

  • BP < 10%

    Clobetasol ≤ 30 g/day.

  • DH

    Coeliac; elbows, knees, buttocks.

  • DH DIF

    Granular IgA, papillary tips.

  • DH treatment

    Dapsone + gluten-free diet.

  • Dapsone

    G6PD first; methaemoglobinaemia.

  • Child < 5, ring of blisters

    Chronic bullous disease of childhood.

  • DIF biopsy

    Perilesional skin.

  • Blister care

    Don't deroof; aspirate 18G.

Sources

Facts in this article were checked against these documents.

  • Standard Treatment Workflow: Immunobullous Dermatoses — Indian Council of Medical Research, DHR, 2022 (link)

  • MSD Manual Professional: Pemphigus Vulgaris; Pemphigus Foliaceus; Bullous Pemphigoid; Dermatitis Herpetiformis — Merck & Co. (MSD Manuals), reviewed 2024–26 (link)

  • Competency Based Undergraduate Curriculum, Dermatology (DR 13) — National Medical Commission, 2024

Test Yourself: Practice Questions

Thirty questions in NEET PG style, most of them clinical vignettes.

Practice Questions (NEET PG pattern)

Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.

Q1. A middle-aged adult has painful oral erosions for months, followed by flaccid blisters and raw erosions on the trunk. The most likely diagnosis is

  • (a) bullous pemphigoid

  • (b) dermatitis herpetiformis

  • (c) pemphigus foliaceus

  • (d) pemphigus vulgaris

Show answer

Answer: (d) — Oral lesions often precede skin.


Q2. The main target antigen in pemphigus vulgaris is

  • (a) type VII collagen

  • (b) tissue transglutaminase

  • (c) desmoglein 3

  • (d) BP180

Show answer

Answer: (c) — Sometimes also desmoglein 1.


Q3. Loss of adhesion between keratinocytes producing an intraepidermal blister is called

  • (a) spongiosis

  • (b) parakeratosis

  • (c) hyperkeratosis

  • (d) acantholysis

Show answer

Answer: (d) — The mechanism of pemphigus.


Q4. Rubbing apparently normal skin next to a blister makes the upper epidermis slide off. This sign is

  • (a) Darier sign

  • (b) Nikolsky sign

  • (c) Koebner phenomenon

  • (d) Auspitz sign

Show answer

Answer: (b) — Positive in pemphigus vulgaris.


Q5. Gentle pressure on an intact bulla makes the fluid spread under the adjacent skin. This is the

  • (a) Asboe-Hansen sign

  • (b) Auspitz sign

  • (c) Darier sign

  • (d) Nikolsky sign

Show answer

Answer: (a) — Also reflects poor epidermal cohesion.


Q6. Direct immunofluorescence in pemphigus vulgaris shows

  • (a) IgG on the keratinocyte cell surface (intercellular)

  • (b) linear IgG along the basement membrane

  • (c) granular IgA in papillary tips

  • (d) no deposits

Show answer

Answer: (a) — Cell-surface (intercellular) pattern.


Q7. Without treatment, pemphigus vulgaris

  • (a) is harmless

  • (b) is often fatal, usually within 5 years

  • (c) always resolves in weeks

  • (d) only scars

Show answer

Answer: (b) — Steroids and immunosuppressants improved prognosis.


Q8. A patient develops superficial skin erosions without mouth lesions after starting captopril. The likely diagnosis and antigen are

  • (a) dermatitis herpetiformis — IgA

  • (b) bullous pemphigoid — BP180

  • (c) pemphigus foliaceus — desmoglein 1

  • (d) pemphigus vulgaris — desmoglein 3

Show answer

Answer: (c) — Also penicillamine, nifedipine.


Q9. An endemic form of pemphigus foliaceus seen in children and young adults in South America is

  • (a) fogo selvagem

  • (b) pemphigus vegetans

  • (c) Hailey–Hailey disease

  • (d) paraneoplastic pemphigus

Show answer

Answer: (a) — Endemic PF.


Q10. ICMR first-line treatment for mucosal or limited (< 5% BSA) pemphigus is

  • (a) dapsone alone at home without monitoring

  • (b) antibiotics only

  • (c) topical steroid only

  • (d) oral prednisolone 0.5 mg/kg/day with an adjuvant such as azathioprine

Show answer

Answer: (d) — Only where monitoring is available.


Q11. Extensive pemphigus at a tertiary centre may be treated with

  • (a) antihistamines

  • (b) topical clobetasol alone

  • (c) dexamethasone–cyclophosphamide pulse therapy or rituximab

  • (d) gluten-free diet

Show answer

Answer: (c) — ICMR tertiary options.


Q12. An 80-year-old has itchy urticarial plaques followed by large tense blisters on the trunk and flexures; Nikolsky sign is negative and the mouth is spared. The diagnosis is

  • (a) pemphigus vulgaris

  • (b) SJS

  • (c) pemphigus foliaceus

  • (d) bullous pemphigoid

Show answer

Answer: (d) — Most common autoimmune blistering disease.


Q13. The antigens targeted in bullous pemphigoid are

  • (a) tissue transglutaminase

  • (b) desmoglein 1 and 3

  • (c) type VII collagen

  • (d) BP180 and BP230 (hemidesmosomal)

Show answer

Answer: (d) — Complement-activating IgG.


Q14. The level of split in bullous pemphigoid is

  • (a) subcorneal

  • (b) within the dermis

  • (c) subepidermal (lamina lucida)

  • (d) suprabasal intraepidermal

Show answer

Answer: (c) — Hence tense blisters.


Q15. Direct immunofluorescence in bullous pemphigoid shows

  • (a) intercellular IgG

  • (b) IgM in vessels

  • (c) linear IgG and C3 along the basement membrane zone

  • (d) granular IgA in papillary tips

Show answer

Answer: (c) — Linear pattern.


Q16. A diabetic patient develops bullous pemphigoid after starting a new oral antidiabetic drug. The likely culprit class is

  • (a) alpha-glucosidase inhibitors

  • (b) DPP-4 inhibitors (gliptins)

  • (c) biguanides

  • (d) sulfonylureas

Show answer

Answer: (b) — Drug-induced pemphigoid.


Q17. ICMR treatment for limited bullous pemphigoid (< 10% BSA) begins with

  • (a) cyclophosphamide pulse

  • (b) rituximab

  • (c) gluten-free diet

  • (d) topical clobetasol propionate up to 30 g/day

Show answer

Answer: (d) — ± prednisolone 0.5 mg/kg, dapsone, doxycycline, niacinamide.


Q18. For extensive bullous pemphigoid (> 10% BSA), ICMR advises

  • (a) prednisolone 0.75–1 mg/kg/day at tertiary level

  • (b) no treatment

  • (c) antibiotics alone

  • (d) topical steroid only at home

Show answer

Answer: (a) — With steroid-sparing agents.


Q19. Doxycycline with niacinamide is an ICMR option in

  • (a) epidermolysis bullosa

  • (b) dermatitis herpetiformis

  • (c) bullous pemphigoid

  • (d) pemphigus vulgaris

Show answer

Answer: (c) — Anti-inflammatory regimen.


Q20. A patient has intensely itchy papulovesicles on the elbows, knees and buttocks. The disease is strongly associated with

  • (a) diabetes

  • (b) coeliac disease

  • (c) hepatitis C

  • (d) HIV

Show answer

Answer: (b) — Dermatitis herpetiformis.


Q21. Direct immunofluorescence in dermatitis herpetiformis shows

  • (a) granular IgA in the dermal papillary tips

  • (b) linear IgA

  • (c) linear IgG along the BMZ

  • (d) intercellular IgG

Show answer

Answer: (a) — Linear IgA = linear IgA disease.


Q22. The drug that rapidly controls the itch of dermatitis herpetiformis is

  • (a) methotrexate

  • (b) cyclosporine

  • (c) prednisolone

  • (d) dapsone

Show answer

Answer: (d) — Plus a gluten-free diet.


Q23. Before starting dapsone, which test is needed to reduce the risk of haemolysis?

  • (a) thyroid function

  • (b) serum IgA

  • (c) G6PD level

  • (d) HLA-B*15:02

Show answer

Answer: (c) — Haemolysis risk is higher in G6PD deficiency.


Q24. A common adverse effect of dapsone is

  • (a) hyperkalaemia

  • (b) methaemoglobinaemia

  • (c) hirsutism

  • (d) gingival hyperplasia

Show answer

Answer: (b) — Also haemolysis, agranulocytosis, dapsone syndrome.


Q25. Long-term control of dermatitis herpetiformis without drugs is possible with

  • (a) sun avoidance

  • (b) a strict gluten-free diet

  • (c) topical steroids

  • (d) antihistamines

Show answer

Answer: (b) — Drug may be stopped later.


Q26. A 3-year-old has erosions surrounded by a ring of tense blisters on an urticarial base around the genitals and face. The likely diagnosis is

  • (a) bullous impetigo only

  • (b) chronic bullous disease of childhood

  • (c) epidermolysis bullosa

  • (d) pemphigus vulgaris

Show answer

Answer: (b) — Linear IgA disease of childhood.


Q27. For direct immunofluorescence, the biopsy should be taken from

  • (a) the centre of an old erosion

  • (b) distant normal skin of the back

  • (c) the blister roof only

  • (d) perilesional skin

Show answer

Answer: (d) — Histology from the lesion margin.


Q28. ICMR advice on intact large blisters is to

  • (a) deroof all blisters

  • (b) apply potent steroid under occlusion

  • (c) excise them

  • (d) avoid deroofing; aspirate with an 18G needle if needed

Show answer

Answer: (d) — The roof is a natural dressing.


Q29. A patient with extensive pemphigus develops fever with rigors, hypotension and confusion. These red flags indicate

  • (a) steroid response

  • (b) drug allergy only

  • (c) fluid loss or sepsis needing urgent care

  • (d) a normal course

Show answer

Answer: (c) — ICMR red flag signs.


Q30. A neonate is born with blisters and erosions. Besides epidermolysis bullosa, ICMR asks you to consider

  • (a) bullous pemphigoid

  • (b) congenital syphilis — VDRL for mother and child

  • (c) pemphigus foliaceus

  • (d) dermatitis herpetiformis

Show answer

Answer: (b) — Bullous lesions in neonates.

Active Recall

From memory: contrast pemphigus vulgaris, pemphigus foliaceus, bullous pemphigoid and dermatitis herpetiformis by antigen, split, blister, mucosa, Nikolsky sign and immunofluorescence, and give the ICMR treatment and general blister care.